Characterization of erythroid cell-derived natural suppressor activity

Immunobiology

Volumn 198, Issue 4, 1998, Pages 361-374

  Seledtsov, Victor I ^a   Seledtsova, Galina V ^a   Samarin, Denis M ^a   Taraban, Vadim Ya ^a   Sennikov, Sergey V ^a   Kozlov, Vladimir A ^a  

^a INSTITUTE OF CLINICAL IMMUNOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTISENSE OLIGODEOXYNUCLEOTIDE; CONCANAVALIN A; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHENYLHYDRAZINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; ERYTHROID CELL; LYMPHOCYTE TRANSFORMATION; MIXED LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; SECONDARY IMMUNE RESPONSE;

EID: 0031886432     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(98)80045-4     Document Type: Article

References (43)

1. DORSHKIND, K., and C. ROSSE. 1982. Physical, biological, and phenotypic properties of natural regulatory cells in murine bone marrow. Am. J. Anat. 164: 1.
2. BAINS, M. A., R. C. MCCARRY, and S. K. SINGHAL. 1982. Regulatory cells in human bone marrow: suppression of an in vitro primary antibody response. Cell. Immunol. 74: 150.
3. MAIER, T., J. N. HOLDA, and H. N. CLAMAN. 1989. Murine natural suppressor cells in the newborn, in bone marrow, and after cyclophosphamide. Genetic variations and dependence on IFN-gamma. J. Immunol. 143: 491.
4. Oseroff, A., Sh. Okada, AND S. Strober. 1984. Natural suppressor (NS) cells found in the spleen of neonatal mice and adult mice given total lymphoid irradiation (TLI) express the null surface phenotype. J. Immunol. 132: 101.
5. WEIGENSBERG, M., S. MORECKI, L. WEISS, Z. FUKS, and S. SLAVIN. 1984. Suppression of cell-mediated immune responses after total lymphoid irradiation (TLI). I Characterization of suppressor cells of mixed lymphocyte reaction. J. Immunol. 132: 971.
6. CHOI K. L., T. MAIER, J. H. HOLDA, and H. N. CLAMAN. 1988. Suppression of cytotoxic T-cell generation by natural suppressor cells from mice with GVHD is partially reversed by indomethacin. Cell. Immuno. 112: 271.
7. BROOKS-KAISER, J. C., L. A. BOURQUE, and D. W. HOSKIN. 1993 Heterogeneity of splenic natural suppressor cells induced in mice by treatment with cyclophosphamide. Immunopharmacology 25: 117.
8. BROOKS, J. C., and D. W. HOSKIN. 1994. The inhibitory effect of cyclophosphamide-induced Mac1+ natural suppressor cells on IL-2 and IL-4 utilization in MLR. Transplantation 58: 1096.
9. SAFFRAN, D. C., and S. K. SINGAL. 1990. Further characterization of murine bone marrow-derived natural suppressor cells: potential relationships between NS and NK/LAK activities. Cell. Immunol. 128: 301.
10. YAMAMOTO, H., M. HIRAYAMA, C. GENYEA, and J. KAPLAN. 1994. TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes. J. Immunol. 152: 3842.
11. SUGIURA, K., M. INABA, H. OGATA, R. YASUMIZU, K. INABA, R. A. GOOD, and S. IKEHARA. 1988. Wheat germ agglutinin-positive cells in a stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity. Proc. Natl. Acad. Sci. USA 85: 4824.
12. HU, Z. Q., T. YAMAZAKI, Z. CAI, T. YOSHIDA, and T. SHIMAMURA. 1994. Mast cells display natural suppressor activity partially by releasing transforming growth factor-beta. Immunology 82: 482.
13. YOUNG, M. R., S. AQUINO, and M. E. YOUNG. 1989. Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants. J. Leuk. Biol. 45: 262.
14. SCHMIDT-WOLF, I. G. H., S. DEJBAKHSH-JONES, N. GINZTON, P. GREENBERG and S. STROBER 1992. T-cell subsets and suppressor cells in human bone marrow. Blood 80: 3242.
15. TSYRLOVA, I. G., N. V. KASHLAKOVA, and V. A. KOZLOV. 1986. Influence of erythropoietic spleenderived cells on proliferation of T and B lymphocytes. Immunologiya (in Russia) No 4: 27.
16. CHEGLYAKOVA, V. V., I. G. TSYRLOVA, and V. A. KOZLOV. 1989. Erythroid nature of bone marrow-derived natural suppressor cells. Immunologiya (in Russia) No 3: 52.
17. SENNIKOV, S. V., V. V. CHEGLYAKOVA, I. G. TSYRLOVA, and V. A. KOZLOV. 1988. Erythroid suppressor cells in regulation of immune reactions. Bul. SO AMN SSSR (in Russia) No 3: 27.
18. MITASOV A. V., I. G. TSYRLOVA, S. V. KISELEV, and V. A. KOZLOV. 1991. Species-nonspecific action of soluble immunosuppressive factor produced by murine immature erytroid cells. Ann. N. Y. Acad. Sci. 628: 399.
19. HOSKIN, D. W., D. A. BOWSER, and J. C. BROOKS-KAISER. 1992. Soybean agglutinin-positive natural suppressor cells in mouse bone-marrow inhibit interleukin-2 production and utilization in mixed lymphocyte reactions. J. Leuk. Biol. 51: 649.
20. MOORE, S. C., M. A. SHAW, and L. S. F. SODERBERG. 1992. Transforming growth factor-beta is the major mediator of natural suppressor cells derived from normal bone-marrow. J. Leuk. Biol. 52: 596.
21. CLEVELAND, M. G., R. G, LANE, and G. R. KLIMPEL. 1988. spontaneous IFN-beta production. A common feature of natural suppressor systems. J. Immunol.. 141: 2043.
22. ANGULO, I., R. RODRIGUEZ, B. GARCIA, M. MEDINA, J. NAVARRO, and J. L. SUBIZA. 1995. Involvement of nitric oxide in bone marrow-derived natural suppressor activity: its dependence on IFN-gamma. J. Immunol. 155: 15.
23. MCGARRY, R. C., R. ANDERSON, and S. K. SINGHAL. 1982. regulation of humoral immune responses by a bone marrow-derived glycolipid-like molecule. Cell. Immunol. 71: 293.
24. MAES. L. Y., J. L. YORK, and L. S. F. SODERBERG. 1988. A soluble factor produced by bone marrow natural suppressor cells blocks interleukin 2 production and activity. Cell. Immunol. 43: 35.
25. VANVLASSELAER, P., T. NIKI, and S. STROBER. 1991. Identification of a factor(s) from cloned murine natural suppressor cells that inhibits IL-2 secretion during antigen-driven T-cell activation. Cell. Immunol. 138: 326.
26. SELEDTSOV, V. I., I. V. AVDEEV, A. V. MORENKOV, G. V. SELEDTSOVA, and V. A. KOZLOV. 1995. Antiproliferative effect of bone marrow cells on leukemic cells. Immunobiology 192: 205.
27. MAGE, M. G-, L. L. MCHUGH, and TH. L. ROTHSTEIN. 1977. Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in purified antiimmunoglobulin. J. Immunol. Meth. 15: 47.
28. JADUS, M. R., and R. PARKMAN. 1985. The selective growth of murine newborn-derived suppressor cells and their probable mode of action. J. Immunol. 136: 783.
29. THILE, D. L., and P. E. LIPSKY. 1985. Regulation of cellular function by products of lysosomal enzyme activity: elimination of human natural killer cells by a dipeptide methyl ester generated from L-leucine methyl ester by monocytes or polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA 82: 2468.
30. SELEDTSOV, V. I., I. V. AVDEEV, G. V. SELEDTSOVA, D. M. SAMARIN, I. V. PROLOPENKO, and V. A. KOZLOV. 1995. Bone arrow cells as cytostatic effectors responsible for suppressing leukemia growth in vitro. Biomed. Pharmacother. 49: 293.
31. MOORE, S. C., S. A. THEUS, J. B. BARNETT, and L. S. F. SODERBERG. 1992. Catokine regulation of bone-marrow natural suppressor cell activity in the suppression of lymphocyte function. Cell. Immunol. 141: 398.
32. SAMARIN, D. M., G. V. SELEDTSOVA, V. I. SELEDTSOV, V. YA. TARABAN, and V. A. KOZLOV. 1997. Characterization of suppressor effect of immature erythroid cells on B-cell proliferation. Bull. Exp. Biol. Med. 123: 66 (in Russia).
33. SELEDTSOVA, G. V., V. I. SELEDTSOV, V. Y. TARABAN, D. M. SAMARIN, and V. A. KOZLOV. 1997. A role for interferon-gamma and transforming growth factor-beta in erythroid cell-mediated regulation of nitric oxide production in macrophages. Immunology 91: 109.
34. SENNIKOV, S. V., L. V. EREMINA, D. M. SAMARIN, I. V. AVDEEV, and V. A. KOZLOV. 1997. Cytokine gene expression in erythroid cells. Eur. Cytokine Netw. 7: 771.
35. CEWENKA, A., D. BEVEC, O. MAJDIC, W. KNAPP, and W. HOLTER. 1994. TGF-beta 1 is a potent inducer of human effector T cells. J. Immunol. 153: 4367.
36. RICH, S., M. SEELIG, H. M. LEE, and J. LIN. 1995. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells. J. Immunol. 155: 609.
37. ZHANG, X., L. GIANGRECO, H. E. BROOME, C. M. DARGAN, and S. L. SWAIN. 1995. Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J. Exp. Med. 182: 699.
38. CHUNCHARUNEE, S., C. D. CARTER, K. E. STUDTMANN, J. CARO, R. J. COFFEY, and E. N. DESSYPRIS. 1993. Chronic administration of transforming growth factor-beta suppresses erythropoietin-dependent erythropoiesis and induces tumour nectrosis factor in vivo. Br. J. Haematol. 84: 374.
39. DYBEDAL, I., and S. E. JACOBSEN. 1995. Transforming growth factor beta (TGF-beta antibodies show erythropoietin as a potent stimulator of murine burst-forming unit erythroid colony formation in the absence of a burst-promoting activity. Blood 86: 949.
40. KRYSTAL, G., V. LAM, W. DRAGOWSKA, C. TAKAHASHI, J. APPEL, A. GONTIER, A. JENKINS, H. LAM, L. QUON, and P. LANSDORP. 1994. Transforming growth factor beta 1 is an inducer of erythroid differentiation. J. Exp. Med. 180: 851.
41. DAINIAK, N., and S. SORBA. 1991. Intracellular regulation of the production and release of human erythroid-directed Lymphokines. J. Clin. Invest. 87: 213.
42. GUHA, A., D. TUCK, S. SORBA, and N. DAINIAK. 1993. Expression of membrane-bound burst-promoting activity is mediated by allogeneic effector cells. Exp. Hematol. 21: 1335.
43. FELDMAN, L., K. L. DAVIS, D. M. FEELEY, A. J. SYTKOWSKI. 1993. A sensitive new bioassay for erythroid colony-stimulating factor. Exp. Hematol. 21: 1657.